<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <titles>
      <item>
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <chamberName />
        <title>A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.</title>
      </item>
      <item>
        <chamberCode />
        <titleType>Display Title</titleType>
        <parentTitleType />
        <chamberName />
        <title>A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.</title>
      </item>
    </titles>
    <notes />
    <latestAction>
      <links />
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <actionDate>2018-04-12</actionDate>
    </latestAction>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2018-04-12T20:39:20Z</date>
            </item>
          </activities>
          <chamber>Senate</chamber>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <type>Standing</type>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <actions>
      <item>
        <actionDate>2018-04-12</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <text>Introduced in Senate</text>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committee />
        <actionDate>2018-04-12</actionDate>
        <actionCode>10000</actionCode>
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <sponsors>
      <item>
        <fullName>Sen. Young, Todd C. [R-IN]</fullName>
        <party>R</party>
        <bioguideId>Y000064</bioguideId>
        <identifiers>
          <lisID>2019</lisID>
          <gpoId>7948</gpoId>
          <bioguideId>Y000064</bioguideId>
        </identifiers>
        <lastName>Young</lastName>
        <byRequestType />
        <middleName>C.</middleName>
        <firstName>Todd</firstName>
        <state>IN</state>
      </item>
    </sponsors>
    <recordedVotes />
    <updateDate>2018-08-28T20:32:07Z</updateDate>
    <billNumber>2665</billNumber>
    <title>A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.</title>
    <relatedBills>
      <item>
        <latestTitle>Opioid Crisis Response Act of 2018</latestTitle>
        <number>2680</number>
        <latestAction>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 398.</text>
          <actionDate>2018-05-07</actionDate>
        </latestAction>
        <type>S</type>
        <congress>115</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <amendments />
    <version>1.0.0</version>
    <laws />
    <cboCostEstimates />
    <billType>S</billType>
    <createDate>2018-04-13T04:26:00Z</createDate>
    <originChamber>Senate</originChamber>
    <summaries>
      <billSummaries />
    </summaries>
    <committeeReports />
    <calendarNumbers />
    <cosponsors>
      <item>
        <fullName>Sen. Donnelly, Joe [D-IN]</fullName>
        <party>D</party>
        <bioguideId>D000607</bioguideId>
        <identifiers>
          <lisID>1850</lisID>
          <gpoId>7941</gpoId>
          <bioguideId>D000607</bioguideId>
        </identifiers>
        <lastName>Donnelly</lastName>
        <sponsorshipDate>2018-04-12</sponsorshipDate>
        <middleName />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>Joe</firstName>
        <state>IN</state>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <introducedDate>2018-04-12</introducedDate>
    <congress>115</congress>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Medical ethics</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

